chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Peripheral swelling
Clinical narrative: swollen lymph nodes; very swollen arm; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (very swollen arm) and LYMPHADENOPATHY (swollen lymph nodes) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On 21-Jan-2021, the patient experienced PERIPHERAL SWELLING (very swollen arm). On 22-Jan-2021, the patient experienced LYMPHADENOPATHY (swollen lymph nodes). On 24-Jan-2021, PERIPHERAL SWELLING (very swollen arm) had resolved. On 25-Jan-2021, LYMPHADENOPATHY (swollen lymph nodes) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided Patient on BRAT diet (bananas, rice apple sauce, tea).
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Condition aggravated, Cough, Dyspnoea, Genital discolouration
Clinical narrative: Genital area worse; Body aches; Chills; Heartbeat increases a little bit; Wasn't feeling well overall/uncomfortable; Genital area is inflamed; Genital area is very pink (penis, lower abdomen); Shortness of breath; Dry cough; A spontaneous report was received from a consumer concerning a 74 years old, male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced shortness of breath, dry cough, body aches(myalgia), chills, heartbeat increased a bit (heart rate increased), was not well overall, uncomfortable (malaise), genital area inflamed (genital tract inflammation), genital area is very pink (penis, lower abdomen) (genital discoloration) and genital area worse (Condition aggravated).   The patient's medical history included heart disorder. Products known to have been used by the patient, within two weeks prior to the event, included blood thinners, supplements and heart medication.  On 03 Feb 2021, prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (Batch number:028L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.   On 03 Feb 2021, the patient experienced shortness of breath and dry cough. On 28 Feb 2021, the patient experienced body aches, chills, heartbeat increased a bit, was not well overall, uncomfortable, genital area inflamed, genital area is very pink (penis, lower abdomen). On 01 Mar 2021, the patient experienced genital area worse.  Treatment for the event included acetaminophen.   Action taken with mRNA-1273 in response to the events was not provided.  The outcome of the events shortness of breath and dry cough, body aches, chills, heartbeat increased a bit, was not well overall, uncomfortable, genital area inflamed, genital area is very pink (penis, lower abdomen) and genital area worse were unknown.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Genital tract inflammation, Heart rate increased, Malaise, Myalgia
Clinical narrative: Genital area worse; Body aches; Chills; Heartbeat increases a little bit; Wasn't feeling well overall/uncomfortable; Genital area is inflamed; Genital area is very pink (penis, lower abdomen); Shortness of breath; Dry cough; A spontaneous report was received from a consumer concerning a 74 years old, male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced shortness of breath, dry cough, body aches(myalgia), chills, heartbeat increased a bit (heart rate increased), was not well overall, uncomfortable (malaise), genital area inflamed (genital tract inflammation), genital area is very pink (penis, lower abdomen) (genital discoloration) and genital area worse (Condition aggravated).   The patient's medical history included heart disorder. Products known to have been used by the patient, within two weeks prior to the event, included blood thinners, supplements and heart medication.  On 03 Feb 2021, prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (Batch number:028L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.   On 03 Feb 2021, the patient experienced shortness of breath and dry cough. On 28 Feb 2021, the patient experienced body aches, chills, heartbeat increased a bit, was not well overall, uncomfortable, genital area inflamed, genital area is very pink (penis, lower abdomen). On 01 Mar 2021, the patient experienced genital area worse.  Treatment for the event included acetaminophen.   Action taken with mRNA-1273 in response to the events was not provided.  The outcome of the events shortness of breath and dry cough, body aches, chills, heartbeat increased a bit, was not well overall, uncomfortable, genital area inflamed, genital area is very pink (penis, lower abdomen) and genital area worse were unknown.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Fatigue, Headache, Heart rate increased
Clinical narrative: numbness; weakness; heart rate went up (HR-150bpm, 146-147 bpm, 97bpm); very, very thirsty; dizzy; fatigue; headache; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (numbness), ASTHENIA (weakness), HEART RATE INCREASED (heart rate went up (HR-150bpm, 146-147 bpm, 97bpm)), THIRST (very, very thirsty) and DIZZINESS (dizzy) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Panic attacks.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, the patient experienced HYPOAESTHESIA (numbness), ASTHENIA (weakness), HEART RATE INCREASED (heart rate went up (HR-150bpm, 146-147 bpm, 97bpm)), THIRST (very, very thirsty), DIZZINESS (dizzy), FATIGUE (fatigue) and HEADACHE (headache). On 27-Feb-2021, HYPOAESTHESIA (numbness), ASTHENIA (weakness), HEART RATE INCREASED (heart rate went up (HR-150bpm, 146-147 bpm, 97bpm)), THIRST (very, very thirsty), DIZZINESS (dizzy) and FATIGUE (fatigue) had resolved. At the time of the report, HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Thirst
Clinical narrative: numbness; weakness; heart rate went up (HR-150bpm, 146-147 bpm, 97bpm); very, very thirsty; dizzy; fatigue; headache; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (numbness), ASTHENIA (weakness), HEART RATE INCREASED (heart rate went up (HR-150bpm, 146-147 bpm, 97bpm)), THIRST (very, very thirsty) and DIZZINESS (dizzy) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Panic attacks.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, the patient experienced HYPOAESTHESIA (numbness), ASTHENIA (weakness), HEART RATE INCREASED (heart rate went up (HR-150bpm, 146-147 bpm, 97bpm)), THIRST (very, very thirsty), DIZZINESS (dizzy), FATIGUE (fatigue) and HEADACHE (headache). On 27-Feb-2021, HYPOAESTHESIA (numbness), ASTHENIA (weakness), HEART RATE INCREASED (heart rate went up (HR-150bpm, 146-147 bpm, 97bpm)), THIRST (very, very thirsty), DIZZINESS (dizzy) and FATIGUE (fatigue) had resolved. At the time of the report, HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pain in extremity
Clinical narrative: Pain in legs causing him to not be able to walk; Muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in legs causing him to not be able to walk) and MYALGIA (Muscle pain) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced PAIN IN EXTREMITY (Pain in legs causing him to not be able to walk) and MYALGIA (Muscle pain). At the time of the report, PAIN IN EXTREMITY (Pain in legs causing him to not be able to walk) and MYALGIA (Muscle pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment details were reported.
Sex: M
Vaccine: COVID19
Symptoms: Refusal of vaccination, Urticaria, Vaccination site pain
Clinical narrative: arm did hurt for a day and a half; His second shot was due today, but he cancelled the appointment; hives; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives), REFUSAL OF VACCINATION (His second shot was due today, but he cancelled the appointment) and VACCINATION SITE PAIN (arm did hurt for a day and a half) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     The patient's past medical history included Hives (The patient had hives before when he has chemicals on him, when he eats shrimp.).    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced URTICARIA (hives). On 01-Mar-2021, the patient experienced REFUSAL OF VACCINATION (His second shot was due today, but he cancelled the appointment). On an unknown date, the patient experienced VACCINATION SITE PAIN (arm did hurt for a day and a half). On 01-Mar-2021, REFUSAL OF VACCINATION (His second shot was due today, but he cancelled the appointment) had resolved. At the time of the report, URTICARIA (hives) and VACCINATION SITE PAIN (arm did hurt for a day and a half) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided.  Reportedly, the patient noticed the hives on 23-Feb-2021 and started taking diphenhydramine (Benadryl) and famotidine (Pepcid). Treatment information was not provided for the events of pain in extremity and product dose omission issue.   The outcome of the events of experienced hives, arm did hurt for a day and half were considered unknown. The outcome of the event his second shot was due today, but he cancelled the appointment was considered resolved.  This report refers to a case of refusal of vaccination (second dose) for mRNA-1273, lot # unknown  with associated AEs vaccination site pain and urticaria. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Reporter's Comments: .; Sender's Comments: This report refers to a case of refusal of vaccination (second dose) for mRNA-1273, lot # unknown  with associated AEs vaccination site pain and urticaria. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     Concomitant products included INSULIN and METFORMIN HCL for an unknown indication.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, the patient experienced HEADACHE (Headache). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] for Headache, at an unspecified dose and frequency. At the time of the report, HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Hypoaesthesia, Insomnia, Laziness
Clinical narrative: Lousy; Headache; Chills; Left side numbness; Rough night sleeping; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Left side numbness), INSOMNIA (Rough night sleeping), LAZINESS (Lousy), HEADACHE (Headache) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 1030M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced HYPOAESTHESIA (Left side numbness), INSOMNIA (Rough night sleeping) and CHILLS (Chills). On 10-Feb-2021, the patient experienced LAZINESS (Lousy) and HEADACHE (Headache). On 10-Feb-2021, HYPOAESTHESIA (Left side numbness) had resolved. At the time of the report, INSOMNIA (Rough night sleeping), LAZINESS (Lousy), HEADACHE (Headache) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Irritability postvaccinal, Pruritus, Rash erythematous
Clinical narrative: Red rash all over other parts of the body; Burning sensation; Itching; Irritation; This spontaneous case was reported by a consumer and describes the occurrence of IRRITABILITY POSTVACCINAL (Irritation), RASH ERYTHEMATOUS (Red rash all over other parts of the body), BURNING SENSATION (Burning sensation) and PRURITUS (Itching) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included ESTRADIOL, LEVOTHYROXINE SODIUM (SYNTHROID), ATENOLOL, IMIPRAMINE, VITAMIN C [ASCORBIC ACID], CALCIUM, MULTIVITAMIN [VITAMINS NOS], FISH OIL, MELATONIN, TOCOPHEROL (VITAMIN E [TOCOPHEROL]), VITAMIN A [RETINOL] and PHYTOMENADIONE (VITAMIN K [PHYTOMENADIONE]) for an unknown indication.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced IRRITABILITY POSTVACCINAL (Irritation). On 07-Feb-2021, the patient experienced RASH ERYTHEMATOUS (Red rash all over other parts of the body), BURNING SENSATION (Burning sensation) and PRURITUS (Itching). At the time of the report, IRRITABILITY POSTVACCINAL (Irritation), RASH ERYTHEMATOUS (Red rash all over other parts of the body), BURNING SENSATION (Burning sensation) and PRURITUS (Itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment included Lisinopril and Triamcinolone-Acetonide
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Lymph node in the neck is swollen; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Lymph node in the neck is swollen) in an 88-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A and Unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 22-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced LYMPHADENOPATHY (Lymph node in the neck is swollen). At the time of the report, LYMPHADENOPATHY (Lymph node in the neck is swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication information was not provided. Concomitant medication was not provided.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness, Pain in extremity
Clinical narrative: hand stiffness; hand hurting; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (hand stiffness) and PAIN IN EXTREMITY (hand hurting) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     Previously administered products included for Influenza immunisation: Flu shot. Past adverse reactions to the above products included Pain in arm with Flu shot.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (hand stiffness) and PAIN IN EXTREMITY (hand hurting). At the time of the report, MUSCULOSKELETAL STIFFNESS (hand stiffness) and PAIN IN EXTREMITY (hand hurting) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No relevant concomitant medication was reported.  No treatment information was provided.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Pyrexia
Clinical narrative: wasn't feeling great; fever 101.7 F; A spontaneous report was received from a consumer concerning a 67-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events like wasn't feeling great, fever of 101.7 f.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On unknown date, prior to the onset of the events the patient received second of two planned doses of mRNA-1273 (lot/batch: Unknown) via unknown route for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the event(s) wasn't feeling great, fever of 101.7 F.  Treatment details included Tylenol.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s) wasn't feeling great, fever of 101, 7 f was unknown.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site reaction, Vaccination site warmth
Clinical narrative: covid arm; warm to the touch; red marking on arm/ redness; Pain in the arm/ hurts/ hurts to touch the red part; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (covid arm), VACCINATION SITE WARMTH (warm to the touch), VACCINATION SITE ERYTHEMA (red marking on arm/ redness) and VACCINATION SITE PAIN (Pain in the arm/ hurts/ hurts to touch the red part) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     Concomitant products included DICLOFENAC, FUROSEMIDE, FEXOFENADINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE (ALLEGRA D), MONTELUKAST, OMEPRAZOLE, AMLODIPINE, GUAIFENESIN (MUCINEX), TIOTROPIUM BROMIDE (SPIRIVA), FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR), SALBUTAMOL (VENTOLIN [SALBUTAMOL]), VITAMIN C [ASCORBIC ACID], VITAMIN E NOS and IRON for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced VACCINATION SITE REACTION (covid arm), VACCINATION SITE WARMTH (warm to the touch), VACCINATION SITE ERYTHEMA (red marking on arm/ redness) and VACCINATION SITE PAIN (Pain in the arm/ hurts/ hurts to touch the red part). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE REACTION (covid arm), VACCINATION SITE WARMTH (warm to the touch), VACCINATION SITE ERYTHEMA (red marking on arm/ redness) and VACCINATION SITE PAIN (Pain in the arm/ hurts/ hurts to touch the red part) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Osteitis
Clinical narrative: "Bad" upper jaw infection; Chills; Fatigue; A spontaneous report was received from a consumer concerning 68-years-old, white female patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and experienced "Bad" upper jaw infection, chills and fatigue.  The patients past medical history included: COPD, Periodontal disease, Jaw infection. The following drugs are known to have been taken by the patient prior to the event: Vitamins.  On 17-Jan 2021, the patient received their first of two planned doses of mRNA-1273 (lot: 032L20A) and on 25 Feb 2021, the patient received second of the of the two planned doses of mRNA-1273 (lot: 023M20A) intramuscularly for prophylaxis of COVID-19 infection.  On 26 Feb 2021, the next morning after the second injection, the patient experienced chills and fatigue that eventually resolved on an unknown date. On 01 Mar 2021, the patient reported that she went to the dentist and was diagnosed with a "bad" upper and lower jaw infection. She reported that the jaw infection was painful, and she was prescribed an unknown antibiotic (seven-day treatment).  The patient received both scheduled doses of mRNA-1273 prior to the events, therefore action taken with the drug in response to the events is not applicable.  The event of "Bad" upper jaw infection was unresolved, while the event of chills and fever were resolved.  The reporter did not provide an assessment for the events "Bad" upper jaw infection, chills and fatigue.; Reporter's Comments: Based on the current available information the event of Bad" upper jaw infection is assessed as unlikely related to mRNA-1273 use.  Event is most likely attributed to the underlying history of Periodontal disease, Jaw infection.  The events of fatigue and chills are consistent with the known safety profile of the vaccine, as such a causal association cannot be excluded.  However, causality is also confounded by the ongoing infection..
Sex: U
Vaccine: COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: patient got Pfizer first dose, Moderna second; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (patient got Pfizer first dose, Moderna second) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (patient got Pfizer first dose, Moderna second). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (patient got Pfizer first dose, Moderna second) outcome was unknown. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications reported.  Treatment: Unknown.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Neck pain, Paraesthesia
Clinical narrative: Neck pain; Slight tingling in fingers; A spontaneous report was received from a consumer concerning a 77-years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events neck pain, slight tingling in fingers.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 26 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 02ZM2014) intramuscularly for prophylaxis of COVID-19 infection.  On 26 Feb 2021, the patient experienced the event(s) neck pain, slight tingling in fingers.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), neck pain, slight tingling in fingers was unknown.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Energy increased, Fatigue, Heart rate increased
Clinical narrative: Bolt of energy; Fast heartbeat; Dizzy; Tired; Weak; A spontaneous report was received from a consumer concerning herself, a 71-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events; dizzy/dizziness, weak/asthenia, tired/fatigue, bolt of energy/increased energy and fast heartbeat/heart rate increased.  The patient's medical history reported include removal of thyroid five years ago, maybe COVID in the beginning of Mar/Apr 2020 as she had no taste or smell  Concomitant medications reported were bupropion, levothyroxine, multivitamins and turmeric.  On 26 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 014M20A) via unknown route in an unspecified arm for prophylaxis of COVID-19 infection.  On 26 Feb 2021, after receiving mRNA-1273, at night the patient felt like her breathing was not as deep as usual. She has a pulse oximeter and upon measuring her levels her oxygen never went below 95, and her pulse was fine. On 27 Feb 2021 the patient felt dizzy and weak. On 28 Feb 2021 the patient felt tired. On 1 Mar 2021 the patient reports waking up early morning with a bolt of energy, which was not normal for her. She describes in further detail as having a fast heartbeat; not rapid, but just like lots of energy. The patient also reported that she did not have injection site reactions (pain, rash, etc.). The patient had her usual lab tests two weeks ago, and all levels were fine. Treatment provided for the events include diphenhydramine.  Action taken with mRNA-1273 in response to the events was unknown.  The outcome of events; dizzy, weak, tired, bolt of energy and fast heartbeat was considered to be unknown.
Age: 80.0
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site swelling
Clinical narrative: Redness at injcetion site; Swelling at injection site; Pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Pain at injection site), VACCINATION SITE ERYTHEMA (Redness at injcetion site) and VACCINATION SITE SWELLING (Swelling at injection site) in an 80-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     The patient's past medical history included Thyroiditis, unspecified and Hypertension.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 02-Feb-2021, the patient experienced VACCINATION SITE PAIN (Pain at injection site). On 10-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness at injcetion site) and VACCINATION SITE SWELLING (Swelling at injection site).   On 03-Feb-2021, VACCINATION SITE PAIN (Pain at injection site) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (Redness at injcetion site) and VACCINATION SITE SWELLING (Swelling at injection site) outcome was unknown. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 23-Apr-2021: NNI
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Dysphagia, Oropharyngeal discomfort, Oropharyngeal pain, Swelling, Throat tightness
Clinical narrative: bump close to the clavicle; Trouble in the throat; Throat is closed; Not able to swallow; Felt like a ball inside her throat from the moment she received the vaccine; Closure of the throat in the left side; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Trouble in the throat), THROAT TIGHTNESS (Throat is closed), DYSPHAGIA (Not able to swallow), OROPHARYNGEAL DISCOMFORT (Felt like a ball inside her throat from the moment she received the vaccine) and THROAT TIGHTNESS (Closure of the throat in the left side) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Pollen allergy (.), Grass allergy, Asthma (Caller is allergic to pollen, grass, cat, dogs and due to this has border asthma.), Osteoporosis and High cholesterol. Concurrent medical conditions included Allergy to animals (Cats) and Allergy to animals (Dogs). Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR) for High cholesterol, ALENDRONATE SODIUM (ALENDRONATE) for Osteoporosis, MULTI VITAMINS & MINERALS, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) and VITAMIN C [ASCORBIC ACID] for an unknown indication.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced OROPHARYNGEAL PAIN (Trouble in the throat), THROAT TIGHTNESS (Throat is closed), DYSPHAGIA (Not able to swallow), OROPHARYNGEAL DISCOMFORT (Felt like a ball inside her throat from the moment she received the vaccine) and THROAT TIGHTNESS (Closure of the throat in the left side). On an unknown date, the patient experienced SWELLING (bump close to the clavicle). At the time of the report, OROPHARYNGEAL PAIN (Trouble in the throat), THROAT TIGHTNESS (Throat is closed), OROPHARYNGEAL DISCOMFORT (Felt like a ball inside her throat from the moment she received the vaccine) and SWELLING (bump close to the clavicle) outcome was unknown, DYSPHAGIA (Not able to swallow) had resolved and THROAT TIGHTNESS (Closure of the throat in the left side) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Reporter contact information, outcome of events, new AE added.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Arm was sore at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Arm was sore at the injection site) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.    The patient's past medical history included No adverse event. Concurrent medical conditions included No adverse event.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, the patient experienced INJECTION SITE PAIN (Arm was sore at the injection site). At the time of the report, INJECTION SITE PAIN (Arm was sore at the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication list was not provided. Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Injection site rash, Pruritus, Vaccination site pain
Clinical narrative: bruise; rash on arm at injection site/started like the size of a quarter now its tripled in size; mild itching; Sore for 2-3 days; This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (bruise), INJECTION SITE RASH (rash on arm at injection site/started like the size of a quarter now its tripled in size), PRURITUS (mild itching) and VACCINATION SITE PAIN (Sore for 2-3 days) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for an unknown indication.  On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced INJECTION SITE RASH (rash on arm at injection site/started like the size of a quarter now its tripled in size), PRURITUS (mild itching) and VACCINATION SITE PAIN (Sore for 2-3 days). On an unknown date, the patient experienced CONTUSION (bruise). At the time of the report, CONTUSION (bruise), INJECTION SITE RASH (rash on arm at injection site/started like the size of a quarter now its tripled in size), PRURITUS (mild itching) and VACCINATION SITE PAIN (Sore for 2-3 days) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.  The patient reported that her pharmacist recommended her to use Benadryl at night and her doctor had advised to put ice on it.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Condition aggravated, Injection site erythema, Injection site warmth, Pruritus
Clinical narrative: warmth on red spots; spots moved to inner arm; spots moved to inner arm; joint pain in knees; red spot/blotches on arm; A spontaneous report was received from a consumer concerning a 86-years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events red spot blotches on arm, warmth on red spots, spots moved to inner arm, itching, joint pain in knees.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 28 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 028L20A) intramuscularly for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the event(s) red spot blotches on arm, warmth on red spots, spots moved to inner arm, itching, joint pain in knees.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), red spot blotches on arm, warmth on red spots, spots moved to inner arm, itching, joint pain in knees was unknown.
Age: 11.0
Sex: U
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: ADMINISTERED TO A 14 YEAR OLD PATIENT; A spontaneous report () was received from a healthcare professional concerning a 14-years old patient of unknown gender, who received two doses of Moderna's covid-19 vaccine (mRNA -1273).  The patient's medical history was not provided. Concomitant medications were not reported.  On 25 FEB 2021, prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (Batch number: 004M20A) via unknown route for prophylaxis of COVID-19 infection.  On 25 FEB 2021, the patient received vaccine at an age of 14 and no other events were reported. No treatment was taken.  Action taken with mRNA-1273 in response to the event was unknown.  At the time of this report, the outcome of the event vaccination at an inappropriate age was unknown.; Reporter's Comments: This case concerns a 14-year-old patient who received their first of two planned doses of mRNA-1273 (Lot unknown), reporting Product administered to patient of inappropriate age without any associated adverse events.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper
Clinical narrative: Pain in stomach; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 17-Feb-2021 and was forwarded to Moderna on 18-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Pain in stomach) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Feb-2021, the patient experienced ABDOMINAL PAIN UPPER (Pain in stomach). At the time of the report, ABDOMINAL PAIN UPPER (Pain in stomach) outcome was unknown. Not Provided          No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not applicable.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 25-Apr-2021: Follow-up information received on 25-Apr-2021 contains no new information.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: 105 Degree F fever; chills; uncontrollable shivering; A spontaneous report  was received from a consumer concerning a 73-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events 105 degree f fever, chills, uncontrollable shivering.  The patient's medical history was not provided. Concomitant medications reported were Extra Strength Tylenol for drug use for unknown indication.  On 10 Feb 2021, prior to the onset of the events the patient received first  dose of two planned doses of mRNA-1273 (lot/batch: unknown) via unknown route for prophylaxis of COVID-19 infection.  On 11 Feb 2021, the patient experienced the event(s) 105 degree f fever, chills, uncontrollable shivering.  Treatment details included Patient's doctor advised her to take Extra Strength Tylenol to decrease the patient's fever and or to, go to the Emergency Department. Fever continued for 24 hours after taking a few doses of, Tylenol Extra Strength..  Action taken with mRNA-1273 in response to the events was not reported.   the outcome of event(s), 105 degree f fever, chills, uncontrollable shivering was resolved.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Tenderness
Clinical narrative: Tenderness on the arm of the injection; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (Tenderness on the arm of the injection) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Allergy (Macrobid Allergy). Concomitant products included APIXABAN (ELIQUIS) for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jan-2021, the patient experienced TENDERNESS (Tenderness on the arm of the injection). On 22-Jan-2021, TENDERNESS (Tenderness on the arm of the injection) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication also include ethylenol .No treatment medications were provided.   This case was linked to MOD-2021-185883 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Follow up was received and reporter contact information was updated.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Dyspnoea
Clinical narrative: stomach issues; shortness of breath; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (stomach issues) and DYSPNOEA (shortness of breath) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included OMEPRAZOLE MAGNESIUM (PRILOSEC [OMEPRAZOLE MAGNESIUM]) for an unknown indication.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, the patient experienced ABDOMINAL DISCOMFORT (stomach issues) and DYSPNOEA (shortness of breath). At the time of the report, ABDOMINAL DISCOMFORT (stomach issues) and DYSPNOEA (shortness of breath) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: Tingling feeling in the left index finger; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling feeling in the left index finger) in a 23-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced PARAESTHESIA (Tingling feeling in the left index finger). At the time of the report, PARAESTHESIA (Tingling feeling in the left index finger) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Relevant concomitant medications was reported.  Treatment information was not provided.   This case was linked to MOD-2021-091434, MOD-2021-091434 (Patient Link).
Age: 54.0
Sex: U
Vaccine: COVID19
Symptoms: Product preparation error
Clinical narrative: administered vaccine after only 4-6 minutes from being taken out of the refrigerator; A spontaneous report was received from a pharmacist () concerning a 54-year-old patient, unknown gender, who was administered a dose of the Moderna vaccine after only 4-6 minutes from being taken out of the refrigerator/ Product preparation error.  The patient's medical history was not provided. No relevant concomitant medications were reported.   On 01 Mar 2021, the patient received their first of two planned doses of mRNA-1273 (Batch number: 013A21A) intramuscularly for prophylaxis of COVID-19 infection.   On 01 Mar 2021, a patient was administered a dose of the Moderna vaccine after only 4-6 minutes from being taken out of the refrigerator. No adverse event was reported by the patient after being given the vaccine. No treatment information was provided.     Action taken with mRNA-1273 in response to the event was not provided.  The event, administered vaccine after only 4-6 minutes from being taken out of the refrigerator, was considered recovered on 01 Mar 2021.; Reporter's Comments: This report refers to a case of Product preparation error for mRNA-1273(Batch number: 013A21A) , with no associated AEs.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site mass, Vaccination site warmth
Clinical narrative: Warm to the touch at the injection site; Knot at the injection site; Red knot at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm to the touch at the injection site), VACCINATION SITE MASS (Knot at the injection site) and VACCINATION SITE ERYTHEMA (Red knot at the injection site) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. uknown) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Warm to the touch at the injection site), VACCINATION SITE MASS (Knot at the injection site) and VACCINATION SITE ERYTHEMA (Red knot at the injection site). At the time of the report, VACCINATION SITE WARMTH (Warm to the touch at the injection site), VACCINATION SITE MASS (Knot at the injection site) and VACCINATION SITE ERYTHEMA (Red knot at the injection site) outcome was unknown. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   No relevant concomitant medications were reported.  No treatment information was provided.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Disorientation, Dizziness, Vaccination site pain
Clinical narrative: woke up and feels disorientated,; walking around and feel a little dizzy; pain the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain the injection site), DISORIENTATION (woke up and feels disorientated,) and DIZZINESS (walking around and feel a little dizzy) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     Concomitant products included FINASTERIDE, LISINOPRIL and BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT) for an unknown indication.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, the patient experienced VACCINATION SITE PAIN (pain the injection site). On 10-Feb-2021, the patient experienced DISORIENTATION (woke up and feels disorientated,) and DIZZINESS (walking around and feel a little dizzy). At the time of the report, VACCINATION SITE PAIN (pain the injection site), DISORIENTATION (woke up and feels disorientated,) and DIZZINESS (walking around and feel a little dizzy) outcome was unknown. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   No treatment details included.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Nausea, Pain
Clinical narrative: Aches all over the body; Chills; Headaches; fever of 100.2; Nausea; Itching at the injection site; Swelling at the injection site; Redness at the injection site; Rash at the injection site; Scratch at the injection site; Soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of SCRATCH (Scratch at the injection site), PAIN (Aches all over the body), VACCINATION SITE PRURITUS (Itching at the injection site), VACCINATION SITE SWELLING (Swelling at the injection site) and VACCINATION SITE PAIN (Soreness at the injection site) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) and IRON for an unknown indication.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, the patient experienced VACCINATION SITE PAIN (Soreness at the injection site). On 26-Feb-2021, the patient experienced SCRATCH (Scratch at the injection site), VACCINATION SITE PRURITUS (Itching at the injection site), VACCINATION SITE SWELLING (Swelling at the injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site) and VACCINATION SITE RASH (Rash at the injection site). On 28-Feb-2021, the patient experienced PAIN (Aches all over the body), CHILLS (Chills), HEADACHE (Headaches), PYREXIA (fever of 100.2) and NAUSEA (Nausea). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Itching, at an unspecified dose and frequency. On 17-Feb-2021, VACCINATION SITE PAIN (Soreness at the injection site) had resolved. On 28-Feb-2021, CHILLS (Chills) had resolved. At the time of the report, SCRATCH (Scratch at the injection site), PAIN (Aches all over the body), VACCINATION SITE PRURITUS (Itching at the injection site), VACCINATION SITE SWELLING (Swelling at the injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site), VACCINATION SITE RASH (Rash at the injection site), HEADACHE (Headaches), PYREXIA (fever of 100.2) and NAUSEA (Nausea) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.2 (High) 100.2.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Changed event outcome from unknown to recovering/resolving